Thus, we performed a meta-analysis, which provided more credible evidence by systematically summarizing all eligible data, to clarify the effects of two IKZF1 polymorphisms (rs4132601 and rs11978267) on childhood ALL as well as AML risk. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.